Alucent Biomedical Funding & Investors
Salt Lake City, UT
Alucent Biomedical is a biomedical company that develops a combination drug-device therapy called Natural Vascular Scaffolding (NVS) for the treatment of vascular diseases. NVS is a first-of-a-kind combination drug-device therapy designed to assist the body in naturally opening and maintaining arterial patency. The therapy focuses on peripheral artery disease (PAD), arteriovenous fistula (AVF) maturation for dialysis, and more.
alucentmedical.comTotal Amount Raised: $46,600,000
Alucent Biomedical Funding Rounds
Series Unknown
$11,200,000
Series B
$34,999,999
Seed
$400,000
Funding info provided by Diffbot.